Skip to main content
Study

High-priority drug-drug interaction clinical decision support overrides in a newly implemented commercial computerized provider order-entry system: override appropriateness and adverse drug events.

Edrees H, Amato MG, Wong A, Seger DL, Bates DW. High-priority drug-drug interaction clinical decision support overrides in a newly implemented commercial computerized provider order-entry system: Override appropriateness and adverse drug events. J Am Med Inform Assoc. 2020;27(6):893-900. doi:10.1093/jamia/ocaa034

Save
Print
May 20, 2020
Edrees H, Amato MG, Wong A, et al. J Am Med Inform Assoc. 2020;27(6):893-900.

Clinical decision support alerts can notify clinicians to potential prescribing errors and potentially avoid adverse drug events. This retrospective study evaluated over 16,000 alerts for drug-drug interactions and found that nearly 96% were overridden by providers; of these overrides, 45.4% were deemed appropriate upon chart review. Alerts for high-priority drug-drug interactions were overridden 87% of the time, and chart review determined that only 0.5% of these alerts were appropriate. The researchers found that 5.1 adverse drug events occurred per 100 overrides. 

Save
Print
Cite
Citation

Edrees H, Amato MG, Wong A, Seger DL, Bates DW. High-priority drug-drug interaction clinical decision support overrides in a newly implemented commercial computerized provider order-entry system: Override appropriateness and adverse drug events. J Am Med Inform Assoc. 2020;27(6):893-900. doi:10.1093/jamia/ocaa034